source
- HHS moves to let compounding pharmacies make select peptides as China tightens biotech exports but permits foreign licensingThe HHS announced a policy that would allow compounding pharmacies to produce certain peptide drugs, expanding access and potentially lowering costs. The move is part of the Trump administration's…
- FDA reviews interim access policy for compounded peptides as Enspryng label expandsThe U.S. Department of Health and Human Services and the Food and Drug Administration have drafted a new interim access policy that would allow compounding pharmacies to use certain peptide drugs u…